|
SP100 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45501405263349E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.96784818942797E-12 |
| Normal-vs-Stage2 |
8.19850000000066E-05 |
| Normal-vs-Stage3 |
2.54519999964842E-07 |
| Normal-vs-Stage4 |
5.41029998579745E-09 |
| Stage1-vs-Stage2 |
3.453000E-01 |
| Stage1-vs-Stage3 |
1.685160E-01 |
| Stage1-vs-Stage4 |
3.312000E-01 |
| Stage2-vs-Stage3 |
9.423000E-01 |
| Stage2-vs-Stage4 |
1.544440E-01 |
| Stage3-vs-Stage4 |
6.236400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67554858876429E-12 |
| Normal-vs-AfricanAmerican |
6.097300E-03 |
| Normal-vs-Asian |
5.364600E-03 |
| Caucasian-vs-AfricanAmerican |
9.877200E-03 |
| Caucasian-vs-Asian |
9.246800E-01 |
| AfricanAmerican-vs-Asian |
3.333200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.56037421767041E-12 |
| Normal-vs-Female |
3.312794483179E-11 |
| Male-vs-Female |
9.041200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.526180E-02 |
| Normal-vs-Age(41-60Yrs) |
2.97706304053236E-12 |
| Normal-vs-Age(61-80Yrs) |
1.32639454974992E-11 |
| Normal-vs-Age(81-100Yrs) |
3.465800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.838400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.936600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.051200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.174800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.358600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.202600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.60320000053282E-07 |
| Normal-vs-Grade 2 |
3.74478226206065E-13 |
| Normal-vs-Grade 3 |
3.92510002278357E-09 |
| Normal-vs-Grade 4 |
3.00780000017653E-07 |
| Grade 1-vs-Grade 2 |
1.412640E-01 |
| Grade 1-vs-Grade 3 |
5.476100E-02 |
| Grade 1-vs-Grade 4 |
2.585800E-01 |
| Grade 2-vs-Grade 3 |
2.540400E-02 |
| Grade 2-vs-Grade 4 |
9.001600E-01 |
| Grade 3-vs-Grade 4 |
1.358410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.4432899320127E-15 |
| Normal-vs-ccB subtype |
1.58730000032747E-07 |
| ccA subtype-vs-ccB subtype |
1.159840E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70750097289374E-11 |
| Normal-vs-N1 |
2.099500E-02 |
| N0-vs-N1 |
9.526400E-01 |
|
|
